DexCom Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares rose 3.42% to $87.65, outperforming competitors Abbott Laboratories and Insulet Corp. during a generally weak market session where the S&P 500 and Dow Jones fell slightly. This marks DexCom's third consecutive day of gains, closing just short of its 52-week high. Trading volume significantly exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) rose 3.42% to $87.65 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
This was the stock's third consecutive day of gains.
DexCom Inc. closed 0.23% short of its 52-week high of $87.85, which the company reached on August 4th.
The stock outperformed some of its competitors Monday, as Abbott Laboratories (ABT) rose 0.75% to $108.62 and Insulet Corp. (PODD) rose 1.19% to $142.85.
Trading volume (7.8 M) eclipsed its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1659ET